180001-34-7CC(N)=NCc1cccc(CN)c1RODUKNYOEVZQPR-UHFFFAOYSA-NN-[3-(aminomethyl)benzyl]acetamidine is an aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase. It has a role as a geroprotector, an angiogenesis inhibitor and an EC 1.14.13.39 (nitric oxide synthase) inhibitor. It is an aralkylamine, a carboxamidine and a primary amino compound.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesA selective inducible nitric oxide synthase (iNOS) inhibitor. A long-acting human iNOS inhibitor possessing an IC50 value of 2.0uM
Uses1400W selectively inhibits inducible nitric oxide synthase. W 1400 has been implicated to prevent Doxorubicin and Trastuzumab induced cardiotoxicity.
No reaction records under the current filter.
Loading…
180001-34-7DTXSID201290729CHEMBL107251、CHEMBL544788CHEBI:90721DefinitionChEBI: N-[3-(aminomethyl)benzyl]acetamidine is an aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase. It has a role as an EC 1.14.13.39 (nitric oxide synthase) inhibitor, a geroprotector and an angiogenesis inhibitor. It is a carboxamidine, an aralkylamine and a primary amino compound.